BTS/NICE/SIGN guideline for asthma 2024: Diagnosis, monitoring and chronic asthma management. How does this compare to GINA 2024?
Open Access
- 11 April 2025
- journal article
- editorial
- Published by Springer Nature in npj Primary Care Respiratory Medicine
- Vol. 35 (1) , 1-5
Abstract
The British BTS/NICE/SIGN Asthma Guideline was launched in November 2024 and represents a major shift in asthma diagnosis and management in the United Kingdom. The British Guideline places emphasis on markers of eosinophilic inflammation as initial key diagnostic tests whereas GINA places emphasis on test of reversible airflow limitation. Both documents acknowledge that there is no one “gold-standard” test and, especially in areas of the world where the is limited or delayed access to tests, the IPCRG “jigsaw puzzle” approach to asthma diagnosis may he particularly useful. The BTS/NICE/SIGN guideline provides strong economic evidence to support the GINA strategy approach of single anti-inflammatory-reliever (AIR) and Maintenance and Reliever (MART) therapies as the cornerstone of asthma management in people age 12 and over.Keywords
This publication has 10 references indexed in Scilit:
- The asthma diagnosis jigsaw puzzle: an adaptable teaching concept to facilitate the diagnosis of asthma in adults and children presenting to primary carenpj Primary Care Respiratory Medicine, 2025
- Asthma diagnosis: a comparison of established diagnostic guidelines in adults with respiratory symptomseClinicalMedicine, 2024
- Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North AmericaThe Journal of Allergy and Clinical Immunology: In Practice, 2022
- Age-specific incidence of allergic and non-allergic asthmaBMC Pulmonary Medicine, 2020
- Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trialThe Lancet, 2019
- Inhaled Combined Budesonide–Formoterol as Needed in Mild AsthmaNew England Journal of Medicine, 2018
- Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent AsthmaJAMA, 2018
- Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trialThe Lancet, 2011
- Global strategy for asthma management and prevention: GINA executive summaryEuropean Respiratory Journal, 2007
- Budesonide/Formoterol Maintenance Plus Reliever TherapyChest, 2006